Red Tree Venture — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

Rondo Therapeuticsrondotx.com inSeries A · Mar 2022 · $67M

Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.

BiotechHealthtech

Shelley Force Aldred(Co-Founder & Chief Executive Officer)in Nathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)

Co-investorsCanaan Partners Dementia Discovery Fund SV Health Investors Johnson & Johnson Innovation – JJDC Novo Holdings

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.